论文部分内容阅读
目的观察肝脾同治法治疗小儿反复呼吸道感染(RRTI)的临床疗效。方法将76例RRTI的患儿随机分为2组,分别采用肝脾同治法、P转移因子口服(P-TFO)法对照治疗,疗程1个月,随访半年。结果肝脾同治法总有效率92.5%和显效率57.5%均明显优于P-TFO法,差异有显著性(P<0.05);治疗后2组患儿血IgG、IgA明显高于治疗前,且肝脾同治法的IgG、IgA高于P-TFO法,而治疗前后各组IgM比较,差异无显著性(P>0.05)。结论肝脾同治法治疗RRTI疗效确切。
Objective To observe the clinical efficacy of treating liver and spleen Tongzhi method in children with recurrent respiratory tract infection (RRTI). Methods Totally 76 children with RRTI were randomly divided into 2 groups. The patients were treated with the method of treating liver and spleen, the method of P transfer factor oral administration (P-TFO). The course of treatment was 1 month and followed up for 6 months. Results The total effective rate of liver and spleen was 92.5% and effective rate of 57.5% were significantly better than the P-TFO method, the difference was significant (P <0.05); after treatment, the two groups of children with serum IgG, IgA was significantly higher than before treatment, And liver and spleen Tongzhi method of IgG, IgA higher than the P-TFO method, and before and after treatment of IgM, the difference was not significant (P> 0.05). Conclusion Liver and spleen Tongzhi method for the treatment of RRTI exact effect.